These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36318679)

  • 1. Lessons Learned from the ISCHEMIA Trial for the Management of Patients with Stable Ischemic Heart Disease.
    Boden WE; Stone PH
    Annu Rev Med; 2023 Jan; 74():189-198. PubMed ID: 36318679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial: Rationale and design.
    ; Maron DJ; Hochman JS; O'Brien SM; Reynolds HR; Boden WE; Stone GW; Bangalore S; Spertus JA; Mark DB; Alexander KP; Shaw L; Berger JS; Ferguson TB; Williams DO; Harrington RA; Rosenberg Y
    Am Heart J; 2018 Jul; 201():124-135. PubMed ID: 29778671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International Study of Comparative Health Effectiveness with Medical and Invasive Approaches-Chronic Kidney Disease (ISCHEMIA-CKD): Rationale and design.
    Bangalore S; Maron DJ; Fleg JL; O'Brien SM; Herzog CA; Stone GW; Mark DB; Spertus JA; Alexander KP; Sidhu MS; Chertow GM; Boden WE; Hochman JS;
    Am Heart J; 2018 Nov; 205():42-52. PubMed ID: 30172098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of the ISCHEMIA Trial on Clinical Practice: an Interventionist's Perspective.
    Mavromatis K; Gershlick A
    Cardiovasc Drugs Ther; 2022 Oct; 36(5):1019-1026. PubMed ID: 34324117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conservative versus invasive stable ischemic heart disease management strategies: what do we plan to learn from the ISCHEMIA trial?
    Cheng-Torres KA; Desai KP; Sidhu MS; Maron DJ; Boden WE
    Future Cardiol; 2016 Jan; 12(1):35-44. PubMed ID: 26696561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Implications of the ISCHEMIA Trial: Invasive vs Conservative Approach in Stable Coronary Disease.
    Choudhary J; Chiu S; Bhugra P; Bikdeli B; Supariwala A; Jauhar R; Chatterjee S
    Curr Cardiol Rep; 2021 Mar; 23(5):43. PubMed ID: 33704597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Appropriate therapy for patients with stable ischemic heart disease: a review of literature and the implication of the International Study of Comparative Effectiveness with Medical and Invasive Approaches trial.
    Guo MH; Nantsios A; Ruel M
    Curr Opin Cardiol; 2020 Nov; 35(6):658-663. PubMed ID: 32941193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of ISCHEMIA in stable ischemic heart disease.
    Spilias N; Zorach B; Denby K; Ellis S
    Cleve Clin J Med; 2020 Jun; 87(7):401-409. PubMed ID: 32636193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Days Alive Out of Hospital With Initial Invasive vs Conservative Management: A Prespecified Analysis of the ISCHEMIA Trial.
    White HD; O'Brien SM; Alexander KP; Boden WE; Bangalore S; Li J; Manjunath CN; Lopez-Sendon JL; Peteiro J; Gosselin G; Berger JS; Maggioni AP; Reynolds HR; Hochman JS; Maron DJ
    JAMA Cardiol; 2021 Sep; 6(9):1023-1031. PubMed ID: 33938917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical Therapy With Versus Without Revascularization in Stable Patients With Moderate and Severe Ischemia: The Case for Community Equipoise.
    Stone GW; Hochman JS; Williams DO; Boden WE; Ferguson TB; Harrington RA; Maron DJ
    J Am Coll Cardiol; 2016 Jan; 67(1):81-99. PubMed ID: 26616030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. After ISCHEMIA: Is cardiac MRI a reliable gatekeeper for invasive angiography and myocardial revascularization?
    Nagel E; Carerj ML; Arendt CT; Puntmann VO
    Herz; 2020 Aug; 45(5):446-452. PubMed ID: 32458013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial Invasive or Conservative Strategy for Stable Coronary Disease.
    Maron DJ; Hochman JS; Reynolds HR; Bangalore S; O'Brien SM; Boden WE; Chaitman BR; Senior R; López-Sendón J; Alexander KP; Lopes RD; Shaw LJ; Berger JS; Newman JD; Sidhu MS; Goodman SG; Ruzyllo W; Gosselin G; Maggioni AP; White HD; Bhargava B; Min JK; Mancini GBJ; Berman DS; Picard MH; Kwong RY; Ali ZA; Mark DB; Spertus JA; Krishnan MN; Elghamaz A; Moorthy N; Hueb WA; Demkow M; Mavromatis K; Bockeria O; Peteiro J; Miller TD; Szwed H; Doerr R; Keltai M; Selvanayagam JB; Steg PG; Held C; Kohsaka S; Mavromichalis S; Kirby R; Jeffries NO; Harrell FE; Rockhold FW; Broderick S; Ferguson TB; Williams DO; Harrington RA; Stone GW; Rosenberg Y;
    N Engl J Med; 2020 Apr; 382(15):1395-1407. PubMed ID: 32227755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health-Status Outcomes with Invasive or Conservative Care in Coronary Disease.
    Spertus JA; Jones PG; Maron DJ; O'Brien SM; Reynolds HR; Rosenberg Y; Stone GW; Harrell FE; Boden WE; Weintraub WS; Baloch K; Mavromatis K; Diaz A; Gosselin G; Newman JD; Mavromichalis S; Alexander KP; Cohen DJ; Bangalore S; Hochman JS; Mark DB;
    N Engl J Med; 2020 Apr; 382(15):1408-1419. PubMed ID: 32227753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced External Counterpulsation (EECP): An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(5):1-70. PubMed ID: 23074496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Implications and Debates on the International Study of Comparative Health Effectiveness with Medical and Invasive Approaches Trial.
    Saito Y; Nishi T; Saito K; Kitahara H; Kawase Y; Matsuo H; Kobayashi Y
    Cardiol Rev; 2022 Sep-Oct 01; 30(5):234-240. PubMed ID: 33758121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implications of the Landmark ISCHEMIA Trial on the Initial Management of High-Risk Patients with Stable Ischemic Heart Disease.
    Vafaei P; Naderi S; Ambrosy AP; Slade JJ
    Curr Atheroscler Rep; 2021 Sep; 23(11):70. PubMed ID: 34468881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial Infarction in the ISCHEMIA Trial: Impact of Different Definitions on Incidence, Prognosis, and Treatment Comparisons.
    Chaitman BR; Alexander KP; Cyr DD; Berger JS; Reynolds HR; Bangalore S; Boden WE; Lopes RD; Demkow M; Piero Perna G; Riezebos RK; McFalls EO; Banerjee S; Bagai A; Gosselin G; O'Brien SM; Rockhold FW; Waters DD; Thygesen KA; Stone GW; White HD; Maron DJ; Hochman JS;
    Circulation; 2021 Feb; 143(8):790-804. PubMed ID: 33267610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial strategy of revascularization versus optimal medical therapy for improving outcomes in ischemic heart disease: a review of the literature.
    Songco AV; Brener SJ
    Curr Cardiol Rep; 2012 Aug; 14(4):397-407. PubMed ID: 22555943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lessons learned from MPI and physiologic testing in randomized trials of stable ischemic heart disease: COURAGE, BARI 2D, FAME, and ISCHEMIA.
    Phillips LM; Hachamovitch R; Berman DS; Iskandrian AE; Min JK; Picard MH; Kwong RY; Friedrich MG; Scherrer-Crosbie M; Hayes SW; Sharir T; Gosselin G; Mazzanti M; Senior R; Beanlands R; Smanio P; Goyal A; Al-Mallah M; Reynolds H; Stone GW; Maron DJ; Shaw LJ
    J Nucl Cardiol; 2013 Dec; 20(6):969-75. PubMed ID: 23963599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial.
    Hochman JS; Reynolds HR; Bangalore S; O'Brien SM; Alexander KP; Senior R; Boden WE; Stone GW; Goodman SG; Lopes RD; Lopez-Sendon J; White HD; Maggioni AP; Shaw LJ; Min JK; Picard MH; Berman DS; Chaitman BR; Mark DB; Spertus JA; Cyr DD; Bhargava B; Ruzyllo W; Wander GS; Chernyavskiy AM; Rosenberg YD; Maron DJ;
    JAMA Cardiol; 2019 Mar; 4(3):273-286. PubMed ID: 30810700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.